ICD-10 code M45.0: Ankylosing spondylitis of multiple sites

Key takeaways

ICD-10 code M45.0 is a billable FY2026 diagnosis code for ankylosing spondylitis of multiple sites in spine.

Documentation must specify multi-site spinal involvement, not a single vertebral region, to justify M45.0 over sibling subcodes M45.1 through M45.9.

Non-radiographic axial spondyloarthritis is coded under the M45.A family, such as M45.AB, not M45.0 or the older M46.80 guidance.

Practice management software like Pabau, with structured client records and digital forms, helps rheumatology practices capture the site-specific documentation M45.0 requires.

ICD-10 code M45.0 is the billable diagnosis code for ankylosing spondylitis of multiple sites in spine, valid for FY2026. It sits inside category M45 (Ankylosing spondylitis) and requires documentation confirming involvement across more than one vertebral region.

Most denied claims trace back to one recurring mistake. The coder selected M45.0 without confirming which spinal sites are affected, or used the non-billable parent code M45 instead of a subcode. This guide covers the subcode hierarchy, documentation rules, common coding errors, and the radiographic-versus-non-radiographic distinction that most coding references barely touch.

ICD-10 code M45.0: Definition, billability, and code overview

According to the CMS ICD-10-CM code set, the M45.0 diagnosis code is valid for FY2026. Its official long descriptor is Ankylosing spondylitis of multiple sites in spine. It belongs to category M45, within block M45-M49 (Spondylopathies), within chapter M00-M99 (Diseases of the Musculoskeletal System and Connective Tissue).

Some coders still search for a general ICD-10 ankylosing spondylitis entry rather than the specific multi-site subcode. Always confirm the full code before billing, since only a site-specific subcode satisfies ICD-10-CM billability rules.

M45 code category: Hierarchy and the full ICD-10 code M45.0 subcode table

M45.0 is one of ten site-specific subcodes within the M45 ankylosing spondylitis diagnosis code category. Each subcode maps to a distinct spinal region.

Selecting M45.0 requires documentation confirming involvement at more than one spinal region, not simply noting that the patient has ankylosing spondylitis (AS). Ankylosing spondylitis of the lumbar region uses M45.6, and ankylosing spondylitis of the lumbosacral region uses M45.7. M45.0 applies only when the physician documents at least two such regions together.

Coders who treat M45 and M45.0 as interchangeable generate a claim that fails ICD-10-CM billability standards, since M45 alone is a non-billable category-level code.

M45.9 (site unspecified) is technically billable but should be avoided when documentation allows specificity. Payers increasingly apply medical necessity criteria requiring site documentation. A claim submitted with M45.9 when the record clearly identifies multiple regions may be flagged for review.

Always verify the current year’s tabular list via the CDC/NCHS ICD-10-CM web tool before submitting.

Approximate synonyms and alternate terms for ICD-10 code M45.0

Clinical notes rarely use the exact ICD-10 long descriptor. Physicians and clinical systems use several interchangeable terms for the same finding. These include a general spondyloarthropathy ICD-10 label, an ICD-10 code for spondyloarthritis, or an older spondyloarthritis ICD-10 entry. Understanding which alternate terms map to M45.0 helps coders locate the right code without ambiguity.

The following terms are recognised synonyms in the ICD-10-CM index:

• Ankylosing spondylitis of multiple sites in spine
• AS involving multiple vertebral levels
• Axial spondylitis (radiographic) of multiple sites
• Bechterew disease involving multiple spinal regions
• Marie-Strumpell disease, multiple sites
• Rheumatoid arthritis of the spine, multiple sites (less current terminology)

An ICD-10 spondylitis entry without further detail is not specific enough to bill. A note that documents “axial spondyloarthritis” without specifying radiographic confirmation does not let the coder assign M45.0 automatically. The same applies to a note that uses an ICD-10 code for spondyloarthropathy generically. The radiographic versus non-radiographic distinction matters significantly here, and is addressed in the differential coding section below.

Clinical documentation requirements for M45.0

Denied claims for ICD-10 code M45.0 typically trace back to one of two documentation failures. Either the physician’s note does not specify which spinal regions are affected, or it lacks the clinical criteria supporting an AS diagnosis. Coders cannot infer multi-site involvement from a general AS diagnosis; the record must confirm it.

Maintaining structured client records that capture site-specific assessment findings reduces this risk substantially. Digital intake forms built around AS documentation fields can prompt rheumatologists to note affected regions before the claim is generated.

The following elements should appear in the clinical record to support M45.0:

• Confirmed AS diagnosis: Physician statement that the patient has ankylosing spondylitis (not merely inflammatory back pain or spondylosis)
• Multi-site spinal involvement: Explicit notation of at least two distinct vertebral regions affected (e.g., lumbar and thoracic; cervical and lumbosacral)
• Imaging findings: Sacroiliitis on X-ray or MRI, or bamboo spine appearance in advanced disease
• Symptom chronology: Morning stiffness lasting more than one hour, onset before age 45, improvement with exercise and not with rest
• HLA-B27 status (supporting, not required): HLA-B27 positivity supports the clinical diagnosis but is not itself a coding criterion; it is a physician-interpreted diagnostic finding

Patients with early axial back pain often see a chiropractor or a physical therapy practice before a rheumatologist confirms AS. Practices running chiropractic practice software or physical therapy EMR software should flag inflammatory red flags early, so the referral happens before structural damage progresses.

Good EHR integration for clinical workflows makes it easier to standardise these documentation fields across encounters. When the chart captures imaging report summaries, symptom duration, and region-specific findings in structured fields, coding accuracy improves.

Common coding errors for ankylosing spondylitis ICD-10 codes

The M45 category generates a predictable set of coding mistakes. Three errors account for the majority of claim problems in rheumatology practices billing ankylosing spondylitis.

Using M45 instead of a specific subcode

M45 is a non-billable category code. Submitting M45 without a subcode suffix results in a claim rejection. Always select from M45.0 through M45.9. Meeting medical office compliance requirements for documentation specificity applies here: the code must be as specific as the medical record supports.

Confusing M45.0 with spondylosis codes

Ankylosing spondylitis (M45.0) is an inflammatory seronegative spondyloarthropathy. Spondylosis (M47 series) is a degenerative condition. These are distinct diagnoses with different clinical presentations and different treatment pathways.

Coders sometimes encounter notes using the terms near each other, particularly in older patients with co-occurring conditions. When documentation is ambiguous, query the physician before selecting M45.0.

A physical exam finding such as the Waddell sign test can flag non-organic pain behavior that points away from an inflammatory diagnosis like AS. It does not replace imaging or lab criteria, but it helps a physician decide whether to pursue a rheumatology workup at all.

Selecting M45.9 when site information is available

M45.9 (site unspecified) is a valid code but represents a documentation failure, not a preferred coding choice. If the physician’s note identifies specific spinal regions, the coder must use the site-specific subcode.

Practices searching for the ICD-10 code for ankylosing spondylitis unspecified, or an ICD-10 ankylosing spondylitis unspecified entry, land on M45.9. Defaulting to M45.9 when M45.0 or another site code is supported may trigger payer audits or medical necessity denials for biologics requiring site-specific justification.

Browse the full ICD-10-CM index for M45 subcodes through the AAPC Codify ICD-10-CM lookup to cross-check code descriptions and official coding notes.

Differential diagnosis: Related ICD-10 codes to consider alongside M45.0

Several ICD-10-CM codes overlap clinically with ankylosing spondylitis of multiple sites in spine. Coders working in rheumatology practices need to distinguish these carefully. The physician’s note may use terms like “spondyloarthritis,” “sacroiliitis,” an undifferentiated spondyloarthropathy ICD-10 label, or “axial SpA” without specifying whether radiographic criteria are met.

Inflammatory back pain ICD-10 codes (including M54.5x series) function as symptom-level codes. They must be replaced by M45.0 once a definitive AS diagnosis is documented. Submitting both M45.0 and M54.50 in the same encounter for the same presentation creates a redundancy that payers may flag.

Coders also see M06.4 and M35.9 turn up in rheumatology charts. Both describe inflammatory or connective-tissue involvement that must be ruled out before a coder confirms M45.0.

ICD-10 code M45.0 vs axial spondyloarthritis: The radiographic distinction coders must know

This distinction causes the most consequential coding errors, and it is the area where competing pages online are thinnest. Axial spondyloarthritis (axial SpA) encompasses two groups: radiographic axial SpA, which is ankylosing spondylitis, and non-radiographic axial SpA. They share clinical features, including HLA-B27 positivity, sacroiliac inflammation, and morning stiffness. They diverge on imaging.

Radiographic axial SpA meets the modified New York criteria: definitive sacroiliitis on plain X-ray (grade 2 bilateral or grade 3-4 unilateral). This is M45.0 territory when multiple spinal sites are involved. Non-radiographic axial SpA has sacroiliac inflammation visible only on MRI, without changes sufficient for plain X-ray grading.

Per ASAS (Assessment of SpondyloArthritis international Society) classification criteria, non-radiographic axial SpA does not map to M45.0. It codes under the M45.A family instead, detailed below.

M45.A0 and the non-radiographic axial spondyloarthritis subcodes

M45.A0 is the ICD-10-CM code for non-radiographic axial spondyloarthritis of unspecified sites in spine. It has been in effect since October 2021 and remains current for FY2026. It sits in a separate M45.A family that mirrors the site structure of M45.0 through M45.9.

M45.AB covers non-radiographic axial spondyloarthritis of multiple sites in spine. It is the direct counterpart to M45.0 when imaging has not yet met the modified New York criteria. Coders select the site-specific M45.A subcode that matches the physician’s documented regions, the same rule that governs M45.0 through M45.9.

Older coding references still point to M46.80 for non-radiographic axial SpA. That guidance predates the M45.A family and no longer reflects the current ICD-10-CM structure.

When a rheumatologist’s note uses “axial SpA” without further qualification, query whether imaging meets modified New York criteria before assigning M45.0. Assigning M45.0 to a non-radiographic patient is an overcoding error that can affect prior-authorization approvals for biologics.

Pharmacological and treatment context for ankylosing spondylitis ICD-10 code claims

M45.0 commonly appears on claims alongside drug administration codes and prior-authorization requests for biologics. Understanding the treatment associations helps coders anticipate what supporting documentation payers may request.

NSAIDs are typically first-line for AS and do not usually require prior authorization. TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab) and IL-17A inhibitors (secukinumab, ixekizumab) are biologics commonly approved for active AS when NSAID therapy has failed.

Payer prior-authorization requirements for these agents vary considerably. Most require documentation of confirmed AS diagnosis, evidence of inadequate NSAID response, and a record of disease activity scores. M45.0 on the claim supports the diagnosis component, but the authorization packet must also include clinical documentation.

Effective claims management software can help practices track prior-authorization status alongside encounter-level coding to reduce delays.

DMARDs such as sulfasalazine are sometimes used for peripheral joint involvement. Evidence for their efficacy in pure axial AS is more limited per rheumatology guidelines. Coders should not infer axial versus peripheral involvement from the drug class alone; that determination requires physician documentation.

How Pabau supports rheumatology documentation and claims accuracy?

Rheumatology practices often lose the M45.0 versus M45.A distinction somewhere between the exam room and the claim. The physician’s note may specify the spinal regions and imaging findings. That detail disappears if the chart does not capture it in a structured field.

Practice management software like Pabau gives rheumatology practices structured client records. These prompt for site-specific findings, imaging results, and symptom chronology at the point of care. Digital intake forms can require this detail before the encounter closes. That way, the documentation supporting M45.0 or the correct M45.A subcode is already in the chart when the claim goes out.

Pabau’s claims management tools track prior-authorization status alongside the encounter, so a missing step-therapy note surfaces before submission instead of after a denial.

Simplify rheumatology documentation and billing

Pabau helps rheumatology practices capture site-specific documentation, manage structured records, and streamline ICD-10 code selection across every encounter. See how it works in a live demo.

Book a demo

Conclusion

Coding ankylosing spondylitis accurately starts with one question: does the record confirm multiple spinal sites? If it does, and imaging shows radiographic AS, M45.0 is correct.

If the note says “axial SpA” without radiographic confirmation, the correct code sits in the M45.A family instead, not M45.0 and not the outdated M46.80. Getting this distinction right protects the claim from denial and keeps prior-authorization packages for biologics moving.

Book a demo to see how Pabau supports the site-specific documentation rheumatology practices need for accurate ICD-10 coding.

Continue your research

Need the code for bone density loss found during a workup? M85.9 covers disorders of bone density and structure when no more specific diagnosis is documented.

Billing for hip osteoarthritis following an old injury? M16.4 applies to bilateral post-traumatic osteoarthritis of the hip.

Coding a knee diagnosis tied to a past trauma? M17.2 covers bilateral post-traumatic osteoarthritis of the knee.

Frequently asked questions